Emerging Vaccine Technologies Market Trends: Quadrivalent Vaccines Provide Broader Protection Against Flu Strains Shaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Vaccine Technologies Market Size Growth Forecast: What to Expect by 2025?
The size of the vaccine technologies market has seen significant growth in recent times. It is projected to rise from $55.59 billion in 2024 to $61.38 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. This growth during the historic period can be credited to factors such as the increasing spread of infectious diseases, larger allocations of government funds towards vaccine research, pandemics outbreaks, greater consciousness about the advantages of vaccines, and the broadening scope of immunization programs.

How Will the Vaccine Technologies Market Size Evolve and Grow by 2029?
The market for vaccine technologies is projected to experience swift expansion in the next several years, reaching $90.17 billion by 2029, with a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this expected surge during the forecast period include the rising need for mRNA vaccines, amplified funding towards personalized vaccines, increased attention to cancer vaccines, higher rates of chronic diseases, and expanding public knowledge about vaccine safety. The key trends predicted during this forecast period include the evolution of mRNA and DNA-based vaccines, the emergence of nanoparticle vaccine delivery systems, the rise in combination vaccines, accelerated adoption of thermostable vaccines, and a focus on needle-free vaccine administration.

View the full report here:
https://www.thebusinessresearchcompany.com/report/vaccine-technologies-global-market-report

What Drivers Are Propelling the Growth of Vaccine Technologies Market Forward?
The escalating incidence of infectious diseases is anticipated to spur the expansion of the vaccine technologies market in the future. Infectious diseases are ailments induced by harmful microorganisms like bacteria, viruses, fungi, or parasites which can transmit directly or indirectly from one individual to another. The uphill incidence of infectious diseases is attributed to the surge in travel, allowing for the swift transmission of pathogens across national boundaries. Vaccine technologies bolster the treatment of infectious diseases by inciting targeted immune responses, effectively preventing and managing infections. These technologies enhance public health initiatives by curbing disease transmission and intensity, thereby improving the overall healthcare results. For instance, as per the UK Health Security Agency, a government entity in the UK, the instances of tuberculosis (an infectious bacterial disease that predominantly impacts the lungs) in England heightened to 4,850 in 2023 from 4,380 cases in 2022, marking a 10.7% increase. Thus, the elevating incidence of infectious diseases is propelling the expansion of the vaccine technologies market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24735&type=smp

Which Emerging Trends Are Transforming the Vaccine Technologies Market in 2025?
Major companies operating in the vaccine technologies market are focusing on developing innovative solutions, such as quadrivalent influenza vaccines, to provide broader immunization coverage and minimize the risk of strain mismatch. Quadrivalent influenza vaccines are vaccines formulated to protect against four influenza virus strains, two influenza A and two influenza B viruses, offering broader protection than trivalent vaccines. For instance, in February 2025, Zydus Lifesciences, an India-based pharmaceutical company, launched VaxiFlu-4, a quadrivalent influenza vaccine. The vaccine offers seasonal protection against four influenza strains, including both influenza A and B types, and is administered as a single-dose intramuscular injection and is suitable for use in both adults and children. It helps reduce the burden of seasonal influenza by offering broader strain coverage compared to traditional trivalent vaccines.

What Are the Key Segments in the Vaccine Technologies Market?
The vaccine technologies market covered in this report is segmented -

1) By Type: Recombinant Or Conjugate Or Subunit, Inactivated, Live Attenuated, Toxoid
2) By Route Of Administration: Parenteral, Oral, Nasal
3) By Disease Indication: Infectious Diseases, Non-Infectious Diseases
4) By Age Group: Pediatric, Adults
5) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Distribution Channels

Subsegments:
1) By Recombinant Or Conjugate Or Subunit: Protein Subunit Vaccines, Virus-Like Particle (VLP) Vaccines, Glycoconjugate Vaccines, Recombinant Vector Vaccines
2) By Inactivated: Whole-Virus Inactivated Vaccines, Split-Virus Inactivated Vaccines, Purified Inactivated Vaccines
3) By Live Attenuated: Viral Live Attenuated Vaccines, Bacterial Live Attenuated Vaccines
4) By Toxoid: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24735&type=smp

Who Are the Key Players Shaping the Vaccine Technologies Market's Competitive Landscape?
Major companies operating in the vaccine technologies market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc, Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Moderna Inc., CSL Limited, Bharat Biotech International Limited, Bavarian Nordic A/S, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd., Emergent BioSolutions Inc., Valneva SE, Novavax Inc., Dynavax Technologies Corporation, CureVac N.V., Inovio Pharmaceuticals Inc, Mitsubishi Tanabe Pharma Corporation.

What Geographic Markets Are Powering Growth in the Vaccine Technologies Market?
North America was the largest region in the vaccine technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24735

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.